title: Myasthenia gravis after BMT: identification of patients at risk?
authors.forename: A
authors.initials: A
authors.lastname: Melms
authors.forename: C
authors.initials: C
authors.lastname: Faul
authors.forename: N
authors.initials: N
authors.lastname: Sommer
authors.forename: H
authors.initials: H
authors.lastname: Wiethölter
authors.forename: C A
authors.initials: CA
authors.lastname: Müller
authors.forename: G
authors.initials: G
authors.lastname: Ehninger
mesh_terms: D000328:Adult; D000741:Anemia, Aplastic / Q000601:surgery; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000276:immunology; D006680:HLA Antigens; D006801:Humans; D008297:Male; D009157:Myasthenia Gravis / Q000209:etiology* / Q000276:immunology; D012307:Risk Factors
chemical_list: D006680:HLA Antigens